126 related articles for article (PubMed ID: 36996627)
21. A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.
Ligero M; Garcia-Ruiz A; Viaplana C; Villacampa G; Raciti MV; Landa J; Matos I; Martin-Liberal J; Ochoa-de-Olza M; Hierro C; Mateo J; Gonzalez M; Morales-Barrera R; Suarez C; Rodon J; Elez E; Braña I; Muñoz-Couselo E; Oaknin A; Fasani R; Nuciforo P; Gil D; Rubio-Perez C; Seoane J; Felip E; Escobar M; Tabernero J; Carles J; Dienstmann R; Garralda E; Perez-Lopez R
Radiology; 2021 Apr; 299(1):109-119. PubMed ID: 33497314
[TBL] [Abstract][Full Text] [Related]
22. Advanced gastric cancer: CT radiomics prediction and early detection of downstaging with neoadjuvant chemotherapy.
Xu Q; Sun Z; Li X; Ye C; Zhou C; Zhang L; Lu G
Eur Radiol; 2021 Nov; 31(11):8765-8774. PubMed ID: 33909133
[TBL] [Abstract][Full Text] [Related]
23. Whole-liver enhanced CT radiomics analysis to predict metachronous liver metastases after rectal cancer surgery.
Liang M; Ma X; Wang L; Li D; Wang S; Zhang H; Zhao X
Cancer Imaging; 2022 Sep; 22(1):50. PubMed ID: 36089623
[TBL] [Abstract][Full Text] [Related]
24. Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy.
Rose AAN; Armstrong SM; Hogg D; Butler MO; Saibil SD; Arteaga DP; Pimentel Muniz T; Kelly D; Ghazarian D; King I; Kamil ZS; Ross K; Spreafico A
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33483342
[TBL] [Abstract][Full Text] [Related]
25. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
[TBL] [Abstract][Full Text] [Related]
26. PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors.
Gabryś HS; Basler L; Burgermeister S; Hogan S; Ahmadsei M; Pavic M; Bogowicz M; Vuong D; Tanadini-Lang S; Förster R; Kudura K; Huellner M; Dummer R; Levesque MP; Guckenberger M
Front Oncol; 2022; 12():977822. PubMed ID: 36505821
[TBL] [Abstract][Full Text] [Related]
27. Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia.
Li L; Wang L; Zeng F; Peng G; Ke Z; Liu H; Zha Y
Eur Radiol; 2021 Oct; 31(10):7901-7912. PubMed ID: 33786655
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.
Keek SA; Kayan E; Chatterjee A; Belderbos JSA; Bootsma G; van den Borne B; Dingemans AC; Gietema HA; Groen HJM; Herder J; Pitz C; Praag J; De Ruysscher D; Schoenmaekers J; Smit HJM; Stigt J; Westenend M; Zeng H; Woodruff HC; Lambin P; Hendriks L
Ther Adv Med Oncol; 2022; 14():17588359221116605. PubMed ID: 36032350
[TBL] [Abstract][Full Text] [Related]
29. Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing Immunotherapy.
Peisen F; Hänsch A; Hering A; Brendlin AS; Afat S; Nikolaou K; Gatidis S; Eigentler T; Amaral T; Moltz JH; Othman AE
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740659
[TBL] [Abstract][Full Text] [Related]
30. CT-Based Radiomics Analysis Before Thermal Ablation to Predict Local Tumor Progression for Colorectal Liver Metastases.
Taghavi M; Staal F; Gomez Munoz F; Imani F; Meek DB; Simões R; Klompenhouwer LG; van der Heide UA; Beets-Tan RGH; Maas M
Cardiovasc Intervent Radiol; 2021 Jun; 44(6):913-920. PubMed ID: 33506278
[TBL] [Abstract][Full Text] [Related]
31. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases.
Wei J; Cheng J; Gu D; Chai F; Hong N; Wang Y; Tian J
Med Phys; 2021 Jan; 48(1):513-522. PubMed ID: 33119899
[TBL] [Abstract][Full Text] [Related]
32. Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
Choi SJ; Park KJ; Heo C; Park BW; Kim M; Kim JK
Clin Radiol; 2021 Aug; 76(8):627.e13-627.e21. PubMed ID: 33762138
[TBL] [Abstract][Full Text] [Related]
33. Ranking the most influential predictors of CT-based radiomics feature values in metastatic lung adenocarcinoma.
Crombé A; Lafon M; Nougaret S; Kind M; Cousin S
Eur J Radiol; 2022 Oct; 155():110472. PubMed ID: 35985090
[TBL] [Abstract][Full Text] [Related]
34. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: A multicentre cohort study.
Li X; Zhang N; Hu C; Lin Y; Li J; Li Z; Cui E; Shi L; Zhuang X; Li J; Lu J; Wang Y; Liu R; Yuan C; Lin H; He J; Ke D; Tang S; Zou Y; He B; Sun C; Chen M; Huang B; Mao R; Feng ST
EClinicalMedicine; 2023 Feb; 56():101805. PubMed ID: 36618894
[TBL] [Abstract][Full Text] [Related]
35. A radiomics model predicts the response of patients with advanced gastric cancer to PD-1 inhibitor treatment.
Liang Z; Huang A; Wang L; Bi J; Kuang B; Xiao Y; Yu D; Hong M; Zhang T
Aging (Albany NY); 2022 Jan; 14(2):907-922. PubMed ID: 35073519
[TBL] [Abstract][Full Text] [Related]
36. Machine Learning Improves the Prediction of Responses to Immune Checkpoint Inhibitors in Metastatic Melanoma.
Tabari A; Cox M; D'Amore B; Mansur A; Dabbara H; Boland G; Gee MS; Daye D
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345037
[TBL] [Abstract][Full Text] [Related]
37. Radiomics-based prediction of response to immune checkpoint inhibitor treatment for solid cancers using computed tomography: a real-world study of two centers.
Yu Y; Bai Y; Zheng P; Wang N; Deng X; Ma H; Yu R; Ma C; Liu P; Xie Y; Wang C; Chen H
BMC Cancer; 2022 Nov; 22(1):1241. PubMed ID: 36451109
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
Wang W; Peng Y; Feng X; Zhao Y; Seeruttun SR; Zhang J; Cheng Z; Li Y; Liu Z; Zhou Z
JAMA Netw Open; 2021 Aug; 4(8):e2121143. PubMed ID: 34410397
[TBL] [Abstract][Full Text] [Related]
39. CT-based radiomics and machine learning to predict spread through air space in lung adenocarcinoma.
Jiang C; Luo Y; Yuan J; You S; Chen Z; Wu M; Wang G; Gong J
Eur Radiol; 2020 Jul; 30(7):4050-4057. PubMed ID: 32112116
[TBL] [Abstract][Full Text] [Related]
40. Deep learning radiomics based on contrast enhanced computed tomography predicts microvascular invasion and survival outcome in early stage hepatocellular carcinoma.
Yang Y; Zhou Y; Zhou C; Ma X
Eur J Surg Oncol; 2022 May; 48(5):1068-1077. PubMed ID: 34862094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
